Health Care Price Certainty for All Americans Act

**Summary of H.R. 9645: Health Care Price Certainty for All Americans Act**

**1. Main Purpose & Objectives** The primary objective of H.R. 9645 is to mandate comprehensive price transparency for hospitals participating in the Medicare program. By requiring the public disclosure of detailed charge and pricing information—including standard charges, payer-specific negotiated rates, and cash prices for shoppable services—the bill aims to empower consumers with data to make informed health care decisions. Ostensibly framed as a consumer protection measure, the underlying intent appears to be market-driven cost containment through increased competition, leveraging transparency as a mechanism to exert downward pressure on prices without direct government price controls.

**2. Key Provisions & Changes to Existing Law** The bill amends Part E of Title XVIII of the Social Security Act by adding a new Section 1899D, titled “Health Care Provider Price Transparency.” Effective January 1, 2027, it imposes three core requirements on “specified hospitals” (those receiving Medicare payments): - **Public Disclosure of Standard Charges**: Hospitals must compile and publish, in a Secretary-established machine-readable format, all standard charges for every item and service provided, updated at least annually. - **Shoppable Service Pricing**: Hospitals must disclose prices for at least 300 shoppable services (a mix of CMS-specified and hospital-selected), including discounted cash prices or median self-pay prices over the prior three years, displayed in a publicly accessible location within the facility. - **Annual Attestation**: Hospitals must submit a signed annual attestation from the CEO, CFO, or equivalent officer affirming the completeness and accuracy of the disclosed information. The bill also mandates the inclusion of plain language descriptions and standardized identifiers (e.g., CPT, HCPCS, DRG, NDC) to enhance usability and comparability.

**3. Affected Parties & Stakeholders** - **Hospitals & Health Systems**: Bear direct compliance costs related to data collection, formatting, publishing, and attestation. Large integrated systems may absorb these costs more easily; smaller or rural hospitals could face disproportionate burdens. - **Health Insurers & Payers**: Required to maintain and provide payer-specific negotiated charges, increasing administrative overhead. May benefit from enhanced benchmarking capabilities but risk exposure of proprietary rate structures. - **Patients & Employers**: Gain access to comparative pricing data, potentially enabling more cost-conscious decision-making, particularly for elective, shoppable services. - **State & Federal Agencies**: CMS assumes enforcement and oversight responsibilities, necessitating rulemaking, monitoring, and potential penalty administration. - **Third-Party Vendors**: Likely to see increased demand for price transparency software, data aggregation, and compliance consulting services.

**4. Potential Impact & Implications** While promoted as a tool for consumer empowerment, the bill’s real-world effect on reducing overall health care spending remains uncertain. Price transparency alone may not drive significant behavioral change, particularly in emergency or non-shoppable care contexts. However, it could intensify price competition in elective procedures and diagnostic imaging, potentially pressuring hospitals to justify rate disparities. From a libertarian-market perspective, the bill represents a restrained regulatory approach—avoiding price caps or direct intervention while using disclosure to simulate market forces. Yet, it expands federal oversight into hospital operations, setting a precedent for broader transparency mandates. Critically, the bill does not address surprise billing, facility fees, or consolidation-driven market power—limiting its systemic impact. For stakeholders focused on efficiency and deregulation, it is a half-measure: more intrusive than ideal, but less damaging than price controls or public option proposals. Ultimately, it may marginally improve market function while entrenching federal administrative oversight—a trade-off favoring incremental reform over transformative change.

**Word Count**: 398

Main Purpose & Objectives: The Health Care Price Certainty for All Americans Act (HR 9645) aims to increase transparency in healthcare pricing by requiring certain Medicare-participating hospitals to publicly disclose detailed pricing information. As I taught you in 8th grade civics—when we covered how Congress uses its spending power to influence policy—the bill leverages Medicare funding conditions to achieve a public health objective that Congress couldn't directly mandate under its enumerated powers. The core goal is simple: give patients access to clear, comparable pricing data so they can make informed decisions about their care, a concept we discussed when learning about consumer protection in healthcare markets.

Key Provisions & Changes to Existing Law: The bill amends Title XVIII of the Social Security Act (Medicare) by adding Section 1899D, which mandates that hospitals receiving Medicare payments must: (1) publish all standard charges for every item and service they provide; (2) disclose prices for at least 300 "shoppable services" (routine procedures like MRIs or colonoscopies where patients can compare costs in advance); (3) present this information in a standardized, machine-readable format established by HHS Secretary; (4) update the data at least annually; and (5) submit an annual attestation from hospital leadership certifying the information's accuracy. Notably, it requires disclosure of both gross charges and payer-specific negotiated rates—addressing the wide variation in what different insurers actually pay for identical services. This builds on but strengthens existing transparency rules from the 2020 Hospital Price Transparency rule, which many hospitals have failed to fully comply with.

Affected Parties & Stakeholders: Hospitals participating in Medicare (nearly all acute care facilities) bear the primary compliance burden, needing to implement systems for collecting, formatting, and publishing complex pricing data. Patients and employers gain potential power to compare costs and negotiate better rates. Health insurers may face pressure as negotiated rates become visible, potentially undermining their ability to secure favorable private deals. Third-party price transparency vendors could see expanded markets for compliance tools. Uninsured patients specifically benefit from required disclosure of discounted cash prices. States may experience reduced uncompensated care costs if price shopping reduces medical debt.

Potential Impact & Implications: If effectively implemented and enforced, this could dramatically increase price competition in healthcare—a market historically plagued by opacity. We learned in civics that informed consumers drive market efficiency; here, patients could avoid surprise bills and select lower-cost providers for elective procedures. However, hospitals argue compliance costs are substantial and that published "charges" often bear little relation to actual payments due to complex insurance negotiations. There's risk of confusion if patients misunderstand list prices versus their actual out-of-pocket costs. Long-term, this might shift bargaining power toward consumers and employers, potentially slowing healthcare cost growth—but only if paired with tools helping patients actually use the data. As we discussed when studying regulatory capture, the real test will be whether HHS enforces compliance meaningfully, or if hospitals find ways to technically comply while obscuring useful information—something we'd have spotted immediately if you'd paid attention during our unit on administrative law.

**Conspiracy Uncle’s Breakdown: HR 9645 – The “Health Care Price Certainty for All Americans Act”**

Alright, folks, gather ’round the turkey and giblets—let’s carve into this bill like it’s hiding alien implants in the stuffing. HR 9645, the so-called “Health Care Price Certainty for All Americans Act,” *sounds* like a gift from Uncle Sam—transparency, fairness, lower costs! But let me tell you: when the government suddenly gets all warm and fuzzy about hospital pricing, you better check if they’re slipping microchips into your IV drip.

**1. Main Purpose & Objectives** On the surface, this bill aims to force hospitals that take Medicare money to slap their prices on a public website—like a hospital version of Amazon, but with more fine print and fewer customer reviews. They want you to see the “standard charges,” “negotiated rates,” and even the “discounted cash price” for 300+ shoppable services (think MRIs, colonoscopies, baby deliveries). The goal? Empower consumers to shop around, drive competition, and finally answer the age-old question: *Why does a Tylenol cost $15 in the ER?* But let’s be real—this isn’t about helping you save money. It’s about data harvesting. Every price you look up? Tracked. Every service you compare? Profiled. The government’s not just making hospitals transparent—it’s building a national health pricing database… and who do you think gets first access? Spoiler: it ain’t you.

**2. Key Provisions & Changes to Existing Law** This bill amends the Social Security Act (Title XVIII—Medicare) to add a new transparency mandate. Starting January 1, 2027, hospitals must: - Publish all standard charges and negotiated prices (by payer) in a machine-readable format. - List prices for at least 300 “shoppable services” in both inpatient and outpatient settings. - Post discounted cash prices (or median self-pay prices if no discount exists). - Submit an annual CEO/CFO-signed attestation swearing the data is accurate—under penalty of perjury, presumably. The Secretary of HHS gets to dictate the format, method, and enforcement. Translation: unelected bureaucrats will decide how hospitals display prices—and what happens if they don’t comply. Fines? Public shaming? Mandatory re-education seminars? You know it’s coming.

**3. Affected Parties & Stakeholders** - **Hospitals:** Big administrative burden. Especially rural and safety-net hospitals that lack IT infrastructure. Expect consolidation—small hospitals get bought out by chains that can afford compliance. - **Insurers:** Their negotiated rates get exposed. Goodbye, secret sweetheart deals. Hello, price wars. - **Patients:** Supposed winners—but will they actually use this data? Most people don’t shop for emergency appendectomies. And what good is price transparency if you’re unconscious in an ambulance? - **Data Brokers & Tech Firms:** Oh, you didn’t think this was just about prices, did you? This bill creates a goldmine of structured, standardized health pricing data—perfect for AI modeling, actuarial prediction, and yes, targeted “wellness” ads that follow you from WebMD to your dreams. - **The Government:** Gains unprecedented insight into hospital economics, payer leverage, and regional pricing disparities. In other words: control.

**4. Potential Impact & Implications** Short-term: Hospitals scream about costs and confusion. Some may game the system—posting misleading “standard charges” nobody actually pays. Long-term: This could usher in real price competition… or it could be a Trojan horse. Once the government has granular pricing data, what’s to stop them from setting reference prices, penalizing “high-cost” providers, or steering patients toward low-cost (i.e., low-quality) options under the guise of “efficiency”? And let’s not forget: price transparency doesn’t address *why* care is so expensive—it just makes

**Summary of H.R. 9645: Health Care Price Certainty for All Americans Act**

**1. Main Purpose & Objectives** The stated purpose of H.R. 9645 is to "promote health care price transparency" by requiring certain Medicare-participating hospitals to disclose detailed pricing information. The bill claims to empower patients with knowledge to make informed decisions, reduce surprise billing, and foster competition in the health care market—framed as a victory for "freedom" and individual choice against opaque, elitist hospital bureaucracies. In true performative fashion, the bill positions itself as a bold strike against the "deep state" of medical pricing secrecy, even as it relies on federal mandates to achieve its goals—a delightful irony not lost on the self-aware observer.

**2. Key Provisions & Changes to Existing Law** The bill amends Title XVIII (Medicare) of the Social Security Act by adding a new Section 1899D, mandating that hospitals receiving Medicare payments must: - Publish all standard charges for every item and service offered, in a machine-readable format and a consumer-friendly display, updated at least annually. - Disclose negotiated rates with specific insurers, discounted cash prices, and median cash prices for self-pay patients. - Provide pricing data for at least 300 "shoppable services" (e.g., MRIs, colonoscopies, knee replacements), including those not offered by the hospital (with disclosures indicating unavailability). - Include plain-language descriptions of services alongside standard billing codes (CPT, DRG, NDC, etc.). - Submit an annual CEO/CFO-signed attestation confirming the accuracy and completeness of the published data. The Secretary of HHS is tasked with establishing the specific methods, formats, and enforcement mechanisms—meaning the real details will emerge through bureaucratic rulemaking, another opportunity for "experts" to interpret congressional intent.

**3. Affected Parties & Stakeholders** - **Hospitals** (especially those billing Medicare): Face new administrative burdens to compile, format, and publish massive datasets, with potential penalties for non-compliance (implied, though not detailed in the excerpt). - **Patients**: Gain access to pricing information that could, in theory, allow comparison shopping—though the usability of such data remains questionable without broader context on quality or outcomes. - **Insurers**: May see negotiated rates exposed, potentially undermining proprietary pricing strategies and altering leverage in future contracts. - **State and Federal Regulators**: Gain a new tool for oversight, though enforcement depends on HHS capacity and political will. - **Health IT Vendors**: Stand to benefit from increased demand for price transparency software and data aggregation platforms. - **The Public**: Invited to marvel at the spectacle of hospitals posting prices like menu items at a diner—while the real drivers of cost (consolidation, drug prices, administrative waste) remain largely untouched.

**4. Potential Impact & Implications** While transparency is a popular bipartisan talking point, the bill’s actual impact on reducing health care costs is uncertain. Critics argue that publishing list prices—often meaningless due to complex insurance negotiations—may confuse rather than inform. Proponents hail it as a free-market solution, ignoring that health care is not a typical consumer market due to urgency, asymmetry of information, and third-party payment. The bill’s true legacy may be symbolic: a performative assertion of congressional concern for "freedom" and "the American people," while avoiding harder reforms. It lets lawmakers claim action on affordability without challenging powerful industry interests. In the end, it’s less about price certainty and more about the *appearance* of certainty—a perfectly crafted episode in the ongoing theater of health care policy, where outrage is manufactured, elites are blamed, and the audience applauds the show.

**Summary of H.R. 9645: Health Care Price Certainty for All Americans Act**

**1. Main Purpose & Objectives** The primary purpose of H.R. 9645 is to enhance health care price transparency by requiring certain Medicare-participating hospitals to publicly disclose detailed pricing information for their services. The bill aims to empower patients with clear, accessible cost data so they can make informed decisions about their care, compare prices across providers, and avoid unexpected medical bills. By promoting price certainty, the legislation seeks to foster greater competition in the health care market and reduce overall costs for consumers and the health care system.

**2. Key Provisions & Changes to Existing Law** The bill amends Title XVIII of the Social Security Act (Medicare) by adding a new Section 1899D, titled “Health Care Provider Price Transparency.” Effective January 1, 2027, it mandates that “specified hospitals” receiving Medicare payments must: - Publish all standard charges (including gross charges and payer-specific negotiated rates) for every item and service offered, in a machine-readable format and a consumer-friendly display. - Provide pricing information for at least 300 “shoppable services” (non-emergency, schedulable procedures), including those specified by CMS and additional hospital-selected services, with plain-language descriptions and standardized identifiers (e.g., CPT, HCPCS, DRG, NDC codes). - Disclose discounted cash prices (or median cash prices from the prior three years if unavailable) for each shoppable service in both inpatient and outpatient settings. - Post this information in a publicly accessible location on the hospital’s website and in a physical location within the facility, updated at least annually. - Submit an annual attestation signed by the hospital’s CEO, CFO, or equivalent official confirming the accuracy and completeness of the published data. The Secretary of Health and Human Services (HHS) is authorized to establish the specific methods, formats, and enforcement mechanisms for compliance.

**3. Affected Parties & Stakeholders** - **Hospitals**: Specifically, Medicare-participating hospitals (referred to as “specified hospitals”) must comply with the disclosure requirements, facing administrative and IT costs to implement and maintain pricing transparency systems. - **Patients/Consumers**: Gain access to detailed, comparable pricing data, enabling better financial planning and provider selection, particularly for elective or scheduled procedures. - **Health Insurers & Payers**: May experience increased negotiation transparency, as payer-specific rates are required to be disclosed, potentially affecting bargaining dynamics. - **Employers & Self-Insured Plans**: Could benefit from clearer cost data when designing health benefits or directing employees to lower-cost providers. - **State & Federal Agencies**: HHS (particularly CMS) will oversee implementation, develop standards, and enforce compliance; state agencies may coordinate oversight. - **Health Care Researchers & Analysts**: Will gain access to standardized, nationwide pricing data for studies on cost variation, market competition, and value-based care.

**4. Potential Impact & Implications** If enacted, the bill could significantly increase price transparency in the U.S. health care system, addressing a long-standing barrier to informed consumer choice. By making negotiated rates and standard charges publicly available, it may reduce price variation for similar services and discourage surprise billing. Over time, increased transparency could stimulate competition among providers, potentially lowering prices for shoppable services. However, hospitals may oppose the bill due to concerns about administrative burden, potential misuse of negotiated rates in future negotiations, and the risk of undermining confidential payer contracts. Implementation challenges include ensuring data accuracy, standardizing complex billing information across diverse systems, and defining enforceable penalties for non-compliance. While the bill focuses on hospitals, it does not currently extend to physicians, ambulatory surgical centers, or other providers, limiting its scope. Nonetheless, it builds on prior transparency rules (such as the 2021 hospital price transparency rule) and could serve as a model for broader reform. Ultimately, the legislation aims to shift the health care market toward greater accountability and consumer empowerment.

**Summary of H.R. 9645: Health Care Price Certainty for All Americans Act**

**1. Main Purpose & Objectives** The primary goal of the Health Care Price Certainty for All Americans Act (H.R. 9645) is to increase transparency in health care pricing by requiring certain Medicare-participating hospitals to publicly disclose detailed, standardized information about their charges and negotiated prices. The bill aims to empower patients with clear, accessible cost information so they can make informed decisions about their care, foster competition among providers, and ultimately reduce surprise billing and overall health care costs. By mandating price transparency, the legislation seeks to address long-standing opacity in health care pricing that has hindered consumer choice and market efficiency.

**2. Key Provisions & Changes to Existing Law** H.R. 9645 amends Title XVIII (Medicare) of the Social Security Act by adding a new Section 1899D, titled “Health Care Provider Price Transparency.” Starting January 1, 2027, all hospitals receiving Medicare payments must: - Publish and update at least annually a comprehensive list of their **standard charges** for every item and service provided. - Disclose **negotiated rates** with third-party payers (insurers) for each service, broken down by inpatient and outpatient settings. - Provide **plain-language descriptions** of services accompanied by standardized billing codes (e.g., CPT, HCPCS, DRG, NDC). - Publish **discounted cash prices** (or median cash prices from the prior three years if no discount exists) for at least 300 “shoppable services” — routine, schedulable procedures like MRIs or colonoscopies — as specified by CMS, with hospitals able to supplement the list if needed. - Clearly indicate which CMS-specified shoppable services they do *not* offer. - Post discounted cash prices in a visible, accessible location within the hospital. - Submit an annual attestation signed by the hospital’s CEO, CFO, or equivalent official confirming the accuracy and completeness of the published data. The Secretary of Health and Human Services (HHS) is tasked with establishing the specific format, methods, and frequency for compliance, ensuring consistency and usability across institutions.

**3. Affected Parties & Stakeholders** - **Hospitals**: All Medicare-participating hospitals (the vast majority of U.S. hospitals) must implement new data collection, reporting, and IT systems to comply, increasing administrative burdens but potentially improving billing clarity. - **Patients/Consumers**: Gain unprecedented access to real, comparable pricing data, enabling better financial planning and provider selection — especially beneficial for the uninsured, underinsured, or those seeking elective care. - **Insurers & Payers**: May face increased negotiation pressure as price disparities become visible; could benefit from reduced billing disputes and greater market efficiency. - **Employers & Health Plans**: Could use the data to design more cost-effective benefit packages and steer employees toward high-value, lower-cost providers. - **Federal Government (HHS/CMS)**: Assumes responsibility for setting standards, monitoring compliance, and enforcing the rule — requiring additional oversight resources. - **Policy Advocates & Researchers**: Gain access to a rich, standardized dataset for analyzing price variation, care utilization, and market dynamics.

**4. Potential Impact & Implications** If effectively implemented, H.R. 9645 could significantly reduce health care price variation and surprise billing by making costs visible and comparable. Increased transparency may drive competition, encouraging hospitals to lower prices or justify premiums based on quality. Over time, this could contribute to slowing health care cost growth. However, challenges include ensuring data accuracy, preventing “gaming” of disclosure requirements, and overcoming potential resistance from hospitals concerned about revealing negotiated rates that could weaken their bargaining power. There’s also risk that consumers may struggle to interpret complex pricing data without adequate support tools. Nonetheless, by aligning with prior transparency rules (like the 2021 hospital price transparency rule), this bill builds on existing efforts to create a more accountable, patient-centered health care system. Success will depend on strong enforcement, user-friendly presentation of data, and complementary policies addressing

**Summary of H.R. 9645: Health Care Price Certainty for All Americans Act**

**1. Main Purpose & Objectives** The primary purpose of H.R. 9645 is to enhance health care price transparency by requiring certain Medicare-participating hospitals to publicly disclose detailed pricing information for their services. The bill aims to empower consumers with accessible, standardized data on hospital charges—including gross charges, payer-specific negotiated rates, and discounted cash prices—so they can make informed decisions and potentially reduce surprise medical billing. By mandating annual public disclosure of standard charges and shoppable services (with a target of at least 300 such services), the legislation seeks to foster competition and accountability in health care pricing.

**2. Key Provisions & Changes to Existing Law** The bill amends Part E of Title XVIII of the Social Security Act (Medicare) by adding a new Section 1899D, titled “Health Care Provider Price Transparency.” Key requirements include: - Beginning January 1, 2027, Medicare-participating hospitals must compile and publish (free of charge, no subscription) all standard charges for every item and service provided. - Hospitals must disclose prices for at least 300 “shoppable services” (routine, schedulable procedures), using CMS-specified and hospital-selected services, with plain-language descriptions and standardized billing codes (e.g., CPT, HCPCS, DRG, NDC). - For each service, hospitals must publish: gross charge, each payer-specific negotiated charge (deidentified), and either the discounted cash price or a three-year median cash price for self-pay patients. - Information must be posted in a publicly accessible location on the hospital’s website and submitted annually to the Secretary of HHS via a signed attestation by the CEO, CFO, or equivalent official confirming data accuracy and completeness. - The Secretary of HHS is authorized to establish the format, method, and frequency of disclosure (minimum annual updates).

**3. Affected Parties & Stakeholders** - **Hospitals** (especially those receiving Medicare payments): Directly affected; must implement systems to track, format, and publish extensive pricing data, increasing administrative and IT burdens. - **Patients/Consumers**: Primary beneficiaries; gain access to comparative pricing data, potentially enabling cost-conscious decision-making. - **Health Insurers & Payers**: Indirectly affected; disclosure of negotiated rates may weaken bargaining power and increase pressure to justify premiums. - **Employers & Self-Insured Plans**: May benefit from greater transparency when designing health benefits or negotiating with providers. - **State & Federal Regulators**: HHS (particularly CMS) gains enforcement authority and oversight responsibilities. - **Health IT Vendors**: Likely to see increased demand for price transparency compliance tools and data aggregation platforms.

**4. Potential Impact & Implications** If enacted, the bill could significantly shift dynamics in health care markets by exposing wide variations in pricing for identical services across and within hospitals. Increased transparency may drive price competition, particularly for shoppable services, and reduce instances of unexpected billing. However, hospitals may resist due to concerns over revealing proprietary negotiated rates, potential patient confusion, or downward pressure on revenues. There is also risk that published “charges” (often inflated list prices) could mislead consumers if not properly contextualized with actual out-of-pocket costs. Enforcement will be critical—without penalties for noncompliance, adherence may be uneven. Over time, the data could fuel broader reforms, including reference-based pricing or all-payer claims database initiatives. While the bill does not directly regulate prices, its transparency mandate represents a significant step toward market-oriented health care reform, aligning with prior executive actions (e.g., Trump administration’s 2019 hospital price transparency rule) but codifying and expanding them into law.

**Monied Interest Analysis** The bill’s sponsor, Rep. Smith (R-MO), has received notable campaign contributions from health care industry PACs, including those representing hospital associations (e.g., American Hospital Association) and medical device manufacturers. While the AHA has historically opposed price transparency mandates citing administrative burden and misinterpretation of charges, some large hospital systems